FIELD: medicine.
SUBSTANCE: invention relates to a local haemostatic agent. Hemostatic agent containing chitosan derivatives and hydrolysed collagen, wherein the chitosan derivatives used are its salt and additionally tannin and arginine, or oligoarginine, or polyarginine, or protamine sulphate, with the following ratio of components, wt.%: chitosan salt 2–4, tannin 1, arginine 1, or oligoarginine 1, or polyarginine 1, or protamine sulphate 1, hydrolysed collagen 20, water—the balance.
EFFECT: use of the invention provides the creation of an effective haemostatic agent with high adhesion, including to a wet wound surface, which does not require additional materials for its fixation.
2 cl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LOCAL HEMOSTATIC AGENT | 2023 |
|
RU2807892C1 |
| COMPOSITION FOR TEMPORARY CONTROL OF BLEEDING | 2023 |
|
RU2819603C1 |
| HAEMOSTATIC AGENT BASED ON POLYVINYLPYRROLIDONE AND METHODS FOR PREPARING ITS PHARMACOLOGICAL FORMS | 2018 |
|
RU2705812C1 |
| METHOD FOR STOPPING BLEEDING USING MODIFIED SODIUM HYALURONATE WITH TROMBIN AND MIRAMISTIN | 2024 |
|
RU2839473C1 |
| THERMO-CONTROLLED COMPOSITION TO STOP BLEEDING TEMPORARY | 2023 |
|
RU2810584C1 |
| MULTILAYER COMBINED LOCAL HAEMOSTATIC AGENT | 2023 |
|
RU2826069C1 |
| HEMOSTATIC SPONGE | 1996 |
|
RU2122867C1 |
| COMBINED HAEMOSTATIC SPONGE | 2023 |
|
RU2836134C1 |
| HAEMOSTATIC SPONGE | 2008 |
|
RU2385726C1 |
| HEMOSTATIC GEL FOR SINGLE TOPICAL APPLICATION | 2023 |
|
RU2796161C1 |
